Heart Failure Flashcards
A 76 year male with height 5’8” and weight of 195 pounds presents to the clinic today with complaints of 4 pound weight gain in the past 7 days.
medical history: hypertension (10 years)
Physical exam (today): peripheral edema +1 bilateral rales
Medications: No know drug allergies,
HCTZ 50 mg po daily
metoprolol tartrate (Lopressor®) 12.5 mg po bid
aspirin 162 mg po daily
chest x-ray (today): lower half of each lung has a cloudy appearance.
What would be the most appropriate treatment option at this time?
a. Hold metoprolol and decrease dose of HCTZ to 25 mg daily.
b. Increase metoprolol tartrate (Lopressor®) 25 mg po bid.
c. Discontinue HCTZ then start furosemide 40 mg now and 20 mg po bid.
d. Start lisinopril 10 mg po daily. e. None of the above are justified choices.
c. Discontinue HCTZ then start furosemide 40 mg now and 20 mg po bid
During a scheduled clinic visit a 65 year old female complains of increasing shortness of breath when walking up one flight of stairs . She is a non-smoker.
Past medical history: hypertension, hyperlipidemia, Congestive heart failure with left ventricular systolic dysfunction (EF 25%)
Chest X-ray (today): enlarged left ventricle and clear lung fields
Physical exam: Weight (today): 78 kg Weight (3 months ago): 79 kg
Vitals (today): blood pressure 121/72 mmHg heart rate: 65 bpm respiratory rate: 12 breaths per minute
Medications: No known drug allergies pravastatin 40mg po every evening, lisinopril 20mg po daily, furosemide 40mg po bid, potassium chloride 20mEq daily, metoprolol succinate (Toprol-XL®) 100mg po daily
Which of the following recommendations would optimize patient’s drug therapy for heart failure?
a. Change metoprolol succinate (Toprol-XL®) to metoprolol tartrate (IR) to lower risk of mortality as confirmed by the COMET trial. b. Add digoxin to reduce hospitalizations (morbidity) as established by the DIG study. c. Add spironolactone to existing therapy to improve survival and prevent hospitalization with the consideration of lowering potassium supplement and a follow-up serum potassium level.
d. Change lisinopril to ramipril due to the SOLVD trial demonstrating a reduction in mortality and morbidity for heart failure patients.
e. Both b and c are reasonable considerations.
e. Both b and c are reasonable considerations.
During a scheduled clinic visit a 65 year old female complains of increasing shortness of breath when walking up one flight of stairs . She is a non-smoker.
Past medical history: hypertension, hyperlipidemia, Congestive heart failure with left ventricular systolic dysfunction (EF 25%)
Chest X-ray (today): enlarged left ventricle and clear lung fields
Physical exam: Weight (today): 78 kg Weight (3 months ago): 79 kg
Vitals (today): blood pressure 121/72 mmHg heart rate: 65 bpm respiratory rate: 12 breaths per minute
Medications: No known drug allergies pravastatin 40mg po every evening, lisinopril 20mg po daily, furosemide 40mg po bid, potassium chloride 20mEq daily, metoprolol succinate (Toprol-XL®) 100mg po daily
What NYHA class & ACC class dose the pt fit into?
NYHA: class 3 ACC: class C
During a scheduled clinic visit a 65 year old female complains of increasing shortness of breath when walking up one flight of stairs . She is a non-smoker.
Past medical history: hypertension, hyperlipidemia, Congestive heart failure with left ventricular systolic dysfunction (EF 25%)
Chest X-ray (today): enlarged left ventricle and clear lung fields
Physical exam: Weight (today): 78 kg Weight (3 months ago): 79 kg
Vitals (today): blood pressure 121/72 mmHg heart rate: 65 bpm respiratory rate: 12 breaths per minute
Medications: No known drug allergies pravastatin 40mg po every evening, lisinopril 20mg po daily, furosemide 40mg po bid, potassium chloride 20mEq daily, metoprolol succinate (Toprol-XL®) 100mg po daily
What lifestyle modification would you recommend to this patient?
Stop smoking
During a scheduled clinic visit a 65 year old female complains of increasing shortness of breath when walking up one flight of stairs . She is a non-smoker.
Past medical history: hypertension, hyperlipidemia, Congestive heart failure with left ventricular systolic dysfunction (EF 25%)
Chest X-ray (today): enlarged left ventricle and clear lung fields
Physical exam: Weight (today): 78 kg Weight (3 months ago): 79 kg
Vitals (today): blood pressure 121/72 mmHg heart rate: 65 bpm respiratory rate: 12 breaths per minute
Medications: No known drug allergies pravastatin 40mg po every evening, lisinopril 20mg po daily, furosemide 40mg po bid, potassium chloride 20mEq daily, metoprolol succinate (Toprol-XL®) 100mg po daily
Based on the medication history, this patient is at risk of developing?
Hyperkalemia due to the ACEI and potassium supplement
During a scheduled clinic visit a 65 year old female complains of increasing shortness of breath when walking up one flight of stairs . She is a non-smoker.
Past medical history: hypertension, hyperlipidemia, Congestive heart failure with left ventricular systolic dysfunction (EF 25%)
Chest X-ray (today): enlarged left ventricle and clear lung fields
Physical exam: Weight (today): 78 kg Weight (3 months ago): 79 kg
Vitals (today): blood pressure 121/72 mmHg heart rate: 65 bpm respiratory rate: 12 breaths per minute
Medications: No known drug allergies pravastatin 40mg po every evening, lisinopril 20mg po daily, furosemide 40mg po bid, potassium chloride 20mEq daily, metoprolol succinate (Toprol-XL®) 100mg po daily
What comorbidites have increased the pt’s risk of HF?
Hypertension
congestive heart failure
A 59 year old male with hight 5’8” and weight of 230 pound is being evaluated today in the hospital from an MI he had 5 days ago after which he had a drug eluting stent placed in his LAD. His chart today indicates pulmonary rales and an echocardiography determines EF of 33%.
Medical history: AMI 5 days ago, hypertension dyslipidemia, smoking a pack of cigarettes per day for the past 25 years
Vitals (today)BP: 138/85 mmHg, HR: 78 bpm.
Medications: No known drug allergies atrovastatin (Lipitor®) 20mg daily, metoprolol tartrate (Lopressor®) 50mg po bid, lisinopril (Zestril®) 20mg po daily, aspirin 162 mg po daily, furosemide (Lasix®) 20mg po bid, nitroglycerin 0.4mg sl prn for chest pain, Nicotine 21 mg apply 1 patch every day
Labs (today): Potassium: 4.0 mEq/L, creatinine 1.1 mg/dL
Based on the EMPHASIS-HF trial, which of the following drug therapy recommendations could be justified for this patient to reduce morbidity and mortality?
a. Change lisinopril to candesartan 4 mg daily. b. Add spironolactone 25 mg po daily.
c. Add eplerenone 25 mg po daily.
d. Add hydrochlorothiazide 12.5 mg daily.
e. None of the above are justified choices based on a specific study.
b. Add spironolactone 25 mg po daily.
c. Add eplerenone 25 mg po daily.
B) current guidelines recommend the addition of any aldosterone antagonists in moderate-sever symptoms & reduced LVEF that can be monitored for renal insufficency
C)This is b/c the EMPHASIS-HF trial showed that pts with moderate- severe symptoms of HF (NYHA II) & LVEF reduction = 35% already being treated with an ACEI/ARB + BB do see reduced risk of cardiovascular death & hospitalization if eplerenone is used.
A 59 year old male with hight 5’8” and weight of 230 pound is being evaluated today in the hospital from an MI he had 5 days ago after which he had a drug eluting stent placed in his LAD. His chart today indicates pulmonary rales and an echocardiography determines EF of 33%.
Medical history: AMI 5 days ago, hypertension dyslipidemia, smoking a pack of cigarettes per day for the past 25 years
Vitals (today)BP: 138/85 mmHg, HR: 78 bpm.
Medications: No known drug allergies atrovastatin (Lipitor®) 20mg daily, metoprolol tartrate (Lopressor®) 50mg po bid, lisinopril (Zestril®) 20mg po daily, aspirin 162 mg po daily, furosemide (Lasix®) 20mg po bid, nitroglycerin 0.4mg sl prn for chest pain, Nicotine 21 mg apply 1 patch every day
Labs (today): Potassium: 4.0 mEq/L, creatinine 1.1 mg/dL
Under which circumstances would a substitution of and ACEI to an ARB be appropriate
substitution is recommended only if there is an intolerance (cough) to the ACEI. Though ARBs have been substituted if the pt has angioedema, for the test this is a contraindication
which agents are recommended when substituting an ARB for an ACEI?
cadnisartan & valsartan
What medications have negative inotropic effects that may precipitate or worsen HF
antiarrhythmic (dispyramide, flecainide, propafenone) BB NDHP CCB (verapamil & diltiazem Oral antifungals ( itraconazole & ternbinafine)
HF can be made worst by cardiotoxic drugs like:
doxorubicin, daunorubicin, cyclophosphamide, ehtanol, amphetamines ( cocaine & meth), trastuzumab & imatinib
Drugs such as NSAIDs, glucocorticoids, rosiglitazone & pioglitazone worsen HF by:
NSAIDs, glucocorticoids, rosiglitazone & pioglitazone cause Na & water retention = increased volume
What is the definition of acute decompensated heart failure?
ADHF is new or worsening signs & symptoms caused by 1) volume overload - wet, 2) hypoperfusion-cold, or both
What the indicators of hypoperfusion
hypotension, renal insufficency, shock, or a combination of these
What are the common cause of ADHF
Medication (noncompliance, add neg. inotrop, NSAIDs, alcohol, illicit drug) Diet noncompliance A.Fib/ arrhythmias MI Uncontrolled HTN PE pneumonia